Roche nabs breakthrough tag for TIGIT cancer immunotherapyRoche’s closely-watched combination of two checkpoint inhibitors – TIGIT-targeting tiragolumab and PD-L1 drug Tecentriq – has claimed breakthrough Share XRoche nabs breakthrough tag for TIGIT cancer immunotherapyhttps://pharmaphorum.com/news/roche-nabs-breakthrough-tag-for-tigit-cancer-immunotherapy/
TIGIT Therapies Digital SummitHarnessing TIGIT Checkpoint Inhibitor Therapies Share XTIGIT Therapies Digital Summithttps://pharmaphorum.com/events/tigit-therapies-digital-summit/